Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : WAND (Milestone Scientific) -- Ignore unavailable to you. Want to Upgrade?

To: A_consumer who wrote (374)	4/9/1998 8:08:00 PM
From: Smart_Asset	Read Replies (1) \| Respond to of 717

A_consumer Thank you. I guess I was assuming that if options for the stock did not exist then I couldn't short it without being what is called naked short. I could very well be wrong on this. Also, after researching a bit more, I don't think there is really any risk at all in being short. Thanks again. Tam

To: A_consumer who wrote (374)	4/11/1998 2:18:00 PM
From: patlew	Read Replies (1) \| Respond to of 717

Mr Consumer During the last conference call Margo Kahn's questions pointed out the fact that new orders for the Wand had dropped precipitously during the last six weeks of Q1. There is also evidence of increasing returns by dentists who are dissatisfied with the Wand. I am trying to determine what percentage of units may have been paid for by the dentists, how the company would account for the returns, and whether the decreasing sales and increasing returns would impact Q1 or Q2 the most. If you have an opinion on this I would appreciate hearing it. If volume is any indication it looks like institutional investors are bailing out along with the CFO.